secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001193125-25-148905
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos stockholders approve charter amendments increasing authorized shares 5x and 2020 Plan share reserve by 1M
--------------------------------------------------------------------------------

- Stockholders approved increase in authorized voting common stock from 20M to 100M shares.
- Stockholders approved increase in authorized non-voting common stock from 800k to 15.8M shares.
- Stockholders approved amendment to 2020 Plan adding 1M shares to the share reserve.
- All three Class II director nominees (Hirth, Preston, Chavez) were elected with ~2.16M votes for.
- Ratification of Ernst & Young as independent auditor for FY2025 approved with 3.43M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312525148905/0001193125-25-148905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312525148905/d98914d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-148905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer